NCLAT Sets Aside Insolvency, Imposes ?10L Costs Following Recusal over Attempt to Influence Member  ||  J&K&L HC: Sec 195 CrPC Bars Cognizance Without Public Servant's Complaint, Not FIR or Investigation  ||  Allahabad HC: Preliminary Issues Barred if Raised 18 Years After Issues Were Framed in a Suit  ||  Guj HC: No Prior Hearing Needed to Dismiss Cop After Corruption Conviction under Article 311(2)(A)  ||  Madras HC: Senior Citizens Act Applies Only To Post-2007 Property Transfers, Not Retrospective  ||  Supreme Court: Private Insurer Not Liable For Accident by Vehicle under State Requisition  ||  SC: Reserved Candidates Can Claim General Seats on Merit with Relaxation if Rules Allow  ||  SC: No Vested Right to Appointment For Next Candidate if Selected One Doesn't Join  ||  Supreme Court Restores Arbitral Award, Rules State Cannot Be Judge in its Own Dispute Case  ||  Delhi HC: Girl Being Friendly on Valentine’s Day Does Not Justify Forced Sexual Activity under POCSO    

Glenmark Settles Patent Litigation over Milnacipran Hydrochloride Tablets - (22 Dec 2015)

Glenmark Pharmaceuticals Inc., USA have entered into a settlement agreement with Forest Laboratories, LLC, Forest Laboratories Holdings, and Royalty Pharma Collection Trust to settle and dismissed outstanding patent litigation related to Glenmark's Abbreviated New Drug Application.

Tags : GLENMARK PHARMACEUTICALS INC   FOREST LABORATORIES   LLC   FOREST LABORATORIES HOLDINGS     ROYALTY PHARMA COLLECTION TRUST  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved